Health Wrap Episode 56 discusses early-onset Alzheimer’s, cancer research paper mills and more

The 56th episode of Health Wrap by The Hindu examines early-onset Alzheimer’s disease, concerns about the reliability of cancer research and challenges in accessing treatment for children with spinal muscular atrophy (SMA).

Ramya Kannan, Health Editor, The Hindu, and Zubeda Hamid, Senior Assistant Editor, The Hindu, discuss how Alzheimer’s disease can affect younger people, the implications of unreliable cancer research, and concerns raised by families over a generic SMA drug.

The episode begins with early-onset Alzheimer’s disease and how the condition can present differently in younger people. The discussion looks at changes in memory, behaviour and everyday functioning, and the challenges of recognising the disease when symptoms appear earlier in life.

Another segment examines cancer research articles flagged for suspected links to paper mills. These businesses produce and sell research papers, sometimes using fabricated data, manipulated images or other questionable research practices. The discussion looks at how unreliable publications can undermine scientific progress, affect future research and complicate efforts to assess the evidence behind medical findings. It also highlights the need for careful investigation, as an article being flagged for suspected links to a paper mill does not, by itself, establish research misconduct.

The episode also looks at concerns raised by families of children living with spinal muscular atrophy (SMA) in Keralam over a generic drug used to treat the rare genetic condition. The concerns have brought questions about the safety, quality and effectiveness of medicines into focus. The discussion examines the importance of reliable information about treatment, regulatory oversight and the challenges families face in accessing medicines for rare diseases, where treatment costs can be a significant barrier.

The final segment revisits the history of Alzheimer’s disease through the case of Auguste Deter. In 1901, German psychiatrist Alois Alzheimer began documenting the symptoms of Deter, a 51-year-old woman who experienced changes in memory, behaviour and her ability to carry out everyday activities. Her symptoms differed from cases he had typically encountered. After her death in 1906, Alzheimer examined her brain and identified changes that contributed to the understanding of the condition later named after him. The segment explores Deter’s experience and the role of clinical observation and patient documentation in the history of medical research.

The episode can also be viewed on The Hindu health page along with the full playlist of The Health Wrap